Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2421459, 12 pages
https://doi.org/10.1155/2017/2421459
Research Article

Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data

Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

Correspondence should be addressed to Zhongxue Fu; moc.621@12509991xzf

Received 4 April 2017; Revised 4 July 2017; Accepted 10 August 2017; Published 25 October 2017

Academic Editor: Siddharth Pratap

Copyright © 2017 Yongfu Xiong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Vasile, A. Olaru, M. Munteanu, I. E. Plesea, Surlin V., and C. Tudorascu, “Prognosis of colorectal cancer: clinical, pathological and therapeutic correlation,” Romanian Journal of Morphology and Embryology, vol. 53, no. 2, pp. 383–391, 2012. View at Google Scholar
  2. X. Luo, B. Burwinkel, S. Tao, and H. Brenner, “MicroRNA signatures: novel biomarker for colorectal cancer?” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 7, pp. 1272–1286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. The Cancer Genome Atlas Network, “Comprehensive molecular characterization of human colon and rectal cancer,” Nature, vol. 487, no. 7407, pp. 330–337, 2012. View at Publisher · View at Google Scholar
  4. L. Hu, H.-Y. Chen, T. Han et al., “Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance,” Tumor Biology, vol. 37, no. 1, pp. 837–845, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Hao, Z. Shu, H. Sun et al., “GRIM-19 expression is a potent prognostic marker in colorectal cancer,” Human Pathology, vol. 46, no. 12, pp. 1815–1820, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. P. D. Dunne, S. Dasgupta, J. K. Blayney et al., “EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer,” Clinical Cancer Research, vol. 22, no. 1, pp. 230–242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Hu, H.-Y. Chen, J. Cai et al., “Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer,” BMC Cancer, vol. 15, no. 1, article no. 246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Xu and Y. Li, “Discovering disease-genes by topological features in human protein-protein interaction network,” Bioinformatics, vol. 22, no. 22, pp. 2800–2805, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Hu, Y. Zhang, J. Ren, Y. Wang, Z. Wang, and J. Zhang, “Statistical approaches for the construction and interpretation of human protein-protein interaction network,” BioMed Research International, vol. 2016, Article ID 5313050, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Vishnubalaji, R. Hamam, M.-H. Abdulla et al., “Genome-wide mRNA and miRNA expression profiling revealmultiple regulatory networks in colorectal cancer,” Cell Death and Disease, vol. 6, no. 1, Article ID e1614, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Liang, C. Li, and J. Zhao, “Identification of key pathways and genes in colorectal cancer using bioinformatics analysis,” Medical Oncology, vol. 33, no. 10, article no. 111, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Huang, H. Duan, and H. Li, “Identification of gene expression pattern related to breast cancer survival using integrated TCGA datasets and genomic tools,” BioMed Research International, vol. 2015, Article ID 878546, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Chang, L. Ma, L. Lin et al., “Identification of novel hub genes associated with liver metastasis of gastric cancer,” International Journal of Cancer, vol. 125, no. 12, pp. 2844–2853, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Zhang, J. Wang, and X. Wang, “Proteogenomic characterization of human colon and rectal cancer,” Nature, vol. 513, no. 7518, pp. 382–387, 2014. View at Publisher · View at Google Scholar
  15. D.-Y. Zhuang, L. I. Jiang, Q.-Q. He, P. Zhou, and T. Yue, “Identification of hub subnetwork based on topological features of genes in breast cancer,” International Journal of Molecular Medicine, vol. 35, no. 3, pp. 664–674, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Jin, W. Wang, G. Du, G. Z. Huang, L. T. Han, Z. Y. Tang et al., “Identifying hub genes and dysregulated pathways in hepatocellular carcinoma,” European Review for Medical and Pharmacological Sciences, vol. 19, no. 4, pp. 592–601, 2015. View at Google Scholar
  17. X. He and J. Zhang, “Why do hubs tend to be essential in protein networks?” PLoS Genetics, vol. 2, no. 6, p. e88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Jeong, S. P. Mason, A. L. Barabási, and Z. N. Oltvai, “Lethality and centrality in protein networks,” Nature, vol. 411, no. 6833, pp. 41-42, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Barabási and Z. N. Oltvai, “Network biology: understanding the cell's functional organization,” Nature Reviews Genetics, vol. 5, no. 2, pp. 101–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Langfelder, P. S. Mischel, and S. Horvath, “When is hub gene selection better than standard meta-analysis?” PLoS ONE, vol. 8, no. 4, Article ID e61505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-Y. Chuang, E. Lee, Y.-T. Liu, D. Lee, and T. Ideker, “Network-based classification of breast cancer metastasis,” Molecular Systems Biology, vol. 3, no. 1, article 140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Wang, M. A. Jensen, and J. C. Zenklusen, “A practical guide to The Cancer Genome Atlas (TCGA),” Methods in Molecular Biology, vol. 1418, pp. 111–141, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Webber, M. Gospodarowicz, L. H. Sobin et al., “Improving the TNM classification: findings from a 10-year continuous literature review,” International Journal of Cancer, vol. 135, no. 2, pp. 371–378, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Robinson, D. J. McCarthy, and G. K. Smyth, “edgeR: a Bioconductor package for differential expression analysis of digital gene expression data,” Bioinformatics, vol. 26, no. 1, pp. 139-140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. G. K. Smyth, “Limma: linear models for microarray data,” in Bioinfor Matics and Computational Biology Solutions Using R and Bioconducto, pp. 397–420, Springer, New York, NY, USA, 2005. View at Google Scholar
  26. G. D. Bader and C. W. V. Hogue, “An automated method for finding molecular complexes in large protein interaction networks,” BMC Bioinformatics, vol. 4, no. 1, p. 2, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. L. Camp, M. Dolled-Filhart, and D. L. Rimm, “X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization,” Clinical Cancer Research, vol. 10, no. 21, pp. 7252–7259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Sakai, M. Fukuyo, K. Ohata et al., “Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway,” International Journal of Cancer, vol. 138, no. 7, pp. 1634–1644, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Sun, L. Wang, S.-C. Guo, X.-B. Wu, and X.-H. Xu, “High-throughput sequencing to identify miRNA biomarkers in colorectal cancer patients,” Oncology Letters, vol. 8, no. 2, pp. 711–713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Dallol, A. Buhmeida, M. S. Al-Ahwal et al., “Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples,” Journal of Translational Medicine, vol. 14, no. 1, article no. 118, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Chang, L. Huang, Q. Cao, and F. Liu, “Identification of colorectal cancer-restricted microRNAs and their target genes based on high-throughput sequencing data,” OncoTargets and Therapy, vol. 9, pp. 1787–1794, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Zhou, X. Xu, J. Wang, J. Lin, and W. Chen, “Identifying miRNA/mRNA negative regulation pairs in colorectal cancer,” Scientific Reports, vol. 5, Article ID 12995, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Pan, J. Lin, and C. T. Le, “How many replicates of arrays are required to detect gene expression changes in microarray experiments? A mixture model approach,” Genome biology, vol. 3, no. 5, p. research0022, 2002. View at Google Scholar · View at Scopus
  34. G. A. Churchill, “Fundamentals of experimental design for cdna microarrays,” Nature Genetics, vol. 32, no. 4S, pp. 490–495, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. N. J. Schurch, P. Schofield, M. Gierliński et al., “How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use?” RNA, vol. 22, no. 6, pp. 839–851, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Dahlem, J. Kurths, M. D. Ferrari, K. Aihara, M. Scheffer, and A. May, “Understanding migraine using dynamic network biomarkers,” Cephalalgia, vol. 35, no. 7, pp. 627–630, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Wu, T. Vallenius, K. Ovaska, J. Westermarck, T. P. Mäkelä, and S. Hautaniemi, “Integrated network analysis platform for protein-protein interactions,” Nature Methods, vol. 6, no. 1, pp. 75–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Linding, L. J. Jensen, G. J. Ostheimer et al., “Systematic discovery of in vivo phosphorylation networks,” Cell, vol. 129, no. 7, pp. 1415–1426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Li and D. W. Heermann, “Transcriptional regulatory network shapes the genome structure of Saccharomyces cerevisiae.,” Nucleus (Austin, Tex.), vol. 4, no. 3, pp. 216–228, 2013. View at Google Scholar · View at Scopus
  40. P. Holme, M. Huss, and H. Jeong, “Subnetwork hierarchies of biochemical pathways,” Bioinformatics, vol. 19, no. 4, pp. 532–538, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Gagneur, D. B. Jackson, and G. Casari, “Hierarchical analysis of dependency in metabolic networks,” Bioinformatics, vol. 19, no. 8, pp. 1027–1034, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Zhang, L. Zhang, H. Li et al., “CXCL3 contributes to CD133+ CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation,” Scientific Reports, vol. 6, Article ID 27426, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. J. I. Risinger, G. L. Maxwell, G. V. R. Chandramouli et al., “Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer,” Cancer Research, vol. 63, no. 1, pp. 6–11, 2003. View at Google Scholar · View at Scopus
  44. H. Huang, X. Pan, H. Jin et al., “PHLPP2 downregulation contributes to lung carcinogenesis following B[a]P/B[a]PDE exposure,” Clinical Cancer Research, vol. 21, no. 16, pp. 3783–3793, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. N. K. Agarwal, X. Zhu, M. Gagea, C. L. White III, G. Cote, and M.-M. Georgescu, “PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase,” Oncotarget, vol. 5, no. 3, pp. 815–823, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Song, S. Xu, H. Zhang et al., “TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway,” Journal of Experimental and Clinical Cancer Research, vol. 35, no. 1, article no. 148, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Shannon, A. Markiel, O. Ozier et al., “Cytoscape: a software Environment for integrated models of biomolecular interaction networks,” Genome Research, vol. 13, no. 11, pp. 2498–2504, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Wang, J. Wei, S. Zhang et al., “Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer,” Oncotarget, vol. 7, no. 52, pp. 86816–86828, 2016. View at Publisher · View at Google Scholar · View at Scopus